Chileka Chiyanika
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Chileka Chiyanika has a total of 59 co-authors. Here are the top co-authors by number of shared publications:
- Winnie Chiu Wing Chu
Department of Imaging and Interventional Radiology, The Chinese University of Hong Kong, Hong Kong SAR, China
4 shared publications - Benson Wui-Man Lau
The Hong Kong Polytechnic University
2 shared publications - Chi-Ming Wong
The Hong Kong Polytechnic University
2 shared publications Chunlei Liu
University of California
2 shared publicationsElizabeth Shumbayawonda
Translational Science Perspectum Diagnostic limited Oxford UK
2 shared publicationsHo Ko
The Chinese University of Hong Kong, Prince of Wales Hospital
2 shared publications
Latest Publications
- Open Access
- 29 October 2026
- Published by SAGE Publications in Journal of Alzheimer's Disease Reports
- Vol. 10
Tau and amyloid show distinct relationships with cognitive decline in Alzheimer's disease: A multimodal PET-MRI study
Background: Amyloid-β (Aβ) and tau show distinct relationships with brain injury in Alzheimer's disease. We evaluated if tau-associated MRI abnormalities persist after accounting Aβ and compared multimodal MRI with PET for classifying cognitive impairment. Multi-parametric MRI provides an accessible framework to capture complementary macrostructural, microstructural, and biophysical tissue alterations across the disease continuum. Objective: To determine whether continuous global cortical tau burden independently relates to regional multi-parametric MRI metrics after controlling for Aβ, and to evaluate how effectively quantitative MRI versus PET markers reflect cognitive status and impairment. Methods: Forty-four participants underwent amyloid/tau PET and advanced MRI (T1 volumetry, DTI, QSM, T1ρ). Covariate-adjusted multivariable linear regressions examined associations of global amyloid and tau burden with regional MRI measures. Mediation and ROC analyses were exploratory. Results: After adjustment for Aβ, higher tau was nominally associated with lower amygdala and putamen fractional anisotropy, but no association survived FDR correction. Conversely, higher Aβ was associated with smaller hippocampal and amygdala volumes and higher hippocampal mean diffusivity, which partly mediated poorer MoCA and HKLLT performance. Hippocampal volume (AUC = 0.949) and mean diffusivity (AUC = 0.928) outperformed tau PET (AUC = 0.733) for classifying cognitive impairment. Conclusions: All cognitively impaired participants were tau-positive, but continuous tau burden showed no clear association with cognition. Hippocampal MRI markers better reflected clinical status.
- 29 October 2026
- Published by SAGE Publications in Journal of Alzheimer's Disease Reports
- Vol. 10
Open AccessTau and amyloid show distinct relationships with cognitive decline in Alzheimer's disease: A multimodal PET-MRI study
Background: Amyloid-β (Aβ) and tau show distinct relationships with brain injury in Alzheimer's disease. We evaluated if tau-associated MRI abnormalities persist after accounting Aβ and compared multimodal MRI with PET for classifying cognitive impairment. Multi-parametric MRI provides an accessible framework to capture complementary macrostructural, microstructural, and biophysical tissue alterations across the disease continuum. Objective: To determine whether continuous global cortical tau burden independently relates to regional multi-parametric MRI metrics after controlling for Aβ, and to evaluate how effectively quantitative MRI versus PET markers reflect cognitive status and impairment. Methods: Forty-four participants underwent amyloid/tau PET and advanced MRI (T1 volumetry, DTI, QSM, T1ρ). Covariate-adjusted multivariable linear regressions examined associations of global amyloid and tau burden with regional MRI measures. Mediation and ROC analyses were exploratory. Results: After adjustment for Aβ, higher tau was nominally associated with lower amygdala and putamen fractional anisotropy, but no association survived FDR correction. Conversely, higher Aβ was associated with smaller hippocampal and amygdala volumes and higher hippocampal mean diffusivity, which partly mediated poorer MoCA and HKLLT performance. Hippocampal volume (AUC = 0.949) and mean diffusivity (AUC = 0.928) outperformed tau PET (AUC = 0.733) for classifying cognitive impairment. Conclusions: All cognitively impaired participants were tau-positive, but continuous tau burden showed no clear association with cognition. Hippocampal MRI markers better reflected clinical status.
- Open Access
- 29 August 2026
- Published by SAGE Publications in Phlebology: The Journal of Venous Disease
Ultrasonographic analysis of effects of seated stretching on popliteal venous haemodynamics after prolonged sitting
Objective: To quantify changes in popliteal vein haemodynamics after 1 hour of sitting and to determine whether a brief seated stretching protocol can improve venous return while maintaining the seated posture. Methods: In this prospective repeated-measures study, 34 healthy adults aged 18-30 years (19 men, 15 women) underwent bilateral popliteal vein assessment after 60 minutes of sitting and again after completion of a brief seated stretching protocol comprising heel raises and hamstring/calf stretching. B-mode and triplex Doppler ultrasound were used to measure popliteal vein cross-sectional area (CSA) and time-averaged mean velocity (TAMV). Volume flow rate (VFR) was calculated as CSA × TAMV. Results: For the whole cohort, CSA did not change significantly ( p = 0.175). In contrast, TAMV increased significantly from 2.40 to 4.04 cm/s (+68.3%, p < 0.001), and VFR increased from 0.77 to 1.62 cm 3 /s (+110.4%, p < 0.001). No significant sex differences were observed in pre-stretching haemodynamic parameters or in post-stretching VFR ( p > 0.05). However, post-stretching CSA was significantly higher in men (0.45 vs 0.31 cm 2 , p = 0.002), whereas post-stretching TAMV was significantly higher in women (4.31 vs 3.65 cm/s, p = 0.015). Conclusion: A brief seated stretching protocol significantly improved popliteal venous return after prolonged sitting, primarily through increased blood flow velocity rather than alteration in venous calibre. This simple, equipment-free intervention may represent a practical strategy for reducing sitting-related venous stasis in sedentary settings. Further studies are required to confirm its clinical value in older and at-risk populations.
- 29 August 2026
- Published by SAGE Publications in Phlebology: The Journal of Venous Disease
Open AccessUltrasonographic analysis of effects of seated stretching on popliteal venous haemodynamics after prolonged sitting
Objective: To quantify changes in popliteal vein haemodynamics after 1 hour of sitting and to determine whether a brief seated stretching protocol can improve venous return while maintaining the seated posture. Methods: In this prospective repeated-measures study, 34 healthy adults aged 18-30 years (19 men, 15 women) underwent bilateral popliteal vein assessment after 60 minutes of sitting and again after completion of a brief seated stretching protocol comprising heel raises and hamstring/calf stretching. B-mode and triplex Doppler ultrasound were used to measure popliteal vein cross-sectional area (CSA) and time-averaged mean velocity (TAMV). Volume flow rate (VFR) was calculated as CSA × TAMV. Results: For the whole cohort, CSA did not change significantly ( p = 0.175). In contrast, TAMV increased significantly from 2.40 to 4.04 cm/s (+68.3%, p < 0.001), and VFR increased from 0.77 to 1.62 cm 3 /s (+110.4%, p < 0.001). No significant sex differences were observed in pre-stretching haemodynamic parameters or in post-stretching VFR ( p > 0.05). However, post-stretching CSA was significantly higher in men (0.45 vs 0.31 cm 2 , p = 0.002), whereas post-stretching TAMV was significantly higher in women (4.31 vs 3.65 cm/s, p = 0.015). Conclusion: A brief seated stretching protocol significantly improved popliteal venous return after prolonged sitting, primarily through increased blood flow velocity rather than alteration in venous calibre. This simple, equipment-free intervention may represent a practical strategy for reducing sitting-related venous stasis in sedentary settings. Further studies are required to confirm its clinical value in older and at-risk populations.
- 15 June 2026
- Published by Universitat Politecnica de Valencia
Academic Performance of Radiography Student Cohorts: A Comparative Study of Virtual Reality Intensity in Human Anatomy Education
This study evaluated how different intensities of virtual reality (VR) in human anatomy course affect radiography students’ performance. Three distinct radiography student cohorts were compared: Cohort 1 (n=121) used traditional methods only; Cohort 2 (n=123) integrated 20 minutes of VR activity into four collaborative sessions in addition to traditional methods; and Cohort 3 (n=102) received six dedicated one-hour VR sessions in addition to traditional teaching. All cohorts followed the same curriculum, were taught by the same team, and completed final examinations based on an identical blueprint. Overall performance differed significantly (p=0.025). Only the intensive VR cohort outperformed the traditional cohort (80.35% vs. 77.31%, p=0.013), effectively raising the average grade from B+ to A‑ and increasing the proportion of A grades. These findings indicate that VR improves anatomy learning only when delivered with sufficient intensity, supporting its use as a structured supplementary tool to help students master complex 3D spatial relationships.
- 15 June 2026
- Published by Universitat Politecnica de Valencia
Academic Performance of Radiography Student Cohorts: A Comparative Study of Virtual Reality Intensity in Human Anatomy Education
This study evaluated how different intensities of virtual reality (VR) in human anatomy course affect radiography students’ performance. Three distinct radiography student cohorts were compared: Cohort 1 (n=121) used traditional methods only; Cohort 2 (n=123) integrated 20 minutes of VR activity into four collaborative sessions in addition to traditional methods; and Cohort 3 (n=102) received six dedicated one-hour VR sessions in addition to traditional teaching. All cohorts followed the same curriculum, were taught by the same team, and completed final examinations based on an identical blueprint. Overall performance differed significantly (p=0.025). Only the intensive VR cohort outperformed the traditional cohort (80.35% vs. 77.31%, p=0.013), effectively raising the average grade from B+ to A‑ and increasing the proportion of A grades. These findings indicate that VR improves anatomy learning only when delivered with sufficient intensity, supporting its use as a structured supplementary tool to help students master complex 3D spatial relationships.
- Open Access
- 17 April 2026
- Published by Elsevier in European Journal of Radiology Open
- Vol. 16, 100749
Development and validation of a fully automated transformer-based 3D framework for pancreatic fat quantification in pancreatic steatosis
- 17 April 2026
- Published by Elsevier in European Journal of Radiology Open
- Vol. 16, 100749
Open AccessDevelopment and validation of a fully automated transformer-based 3D framework for pancreatic fat quantification in pancreatic steatosis
- 28 February 2025
- Published by SAGE Publications in Journal of Diagnostic Medical Sonography
- Vol. 41 (6) , 575-582
Effects of Low-Fat Food on Gallbladder Contraction and Sonographic Image Quality
Objective: The aim of this study was to examine the impact of consuming a navel orange, a low-fat food item, on gallbladder contraction and sonographic image quality. Materials and Methods: Sixty-six healthy Chinese participants underwent sonographic evaluation of their gallbladder volume (GBV) and anterior wall thickness (AWT) after fasting for at least 6 hours. This protocol was repeated 120 minutes after consuming a navel orange. An experienced sonographer rated the quality of the gallbladder images on a five-point Likert scale. Results: There was no significant change in GBV (14.15 cm³ preprandial vs 14.00 cm³ postprandial, p =.073), AWT (0.154 cm vs 0.157 cm, p =.101), or image quality (both rated 5, p =1.000) after orange intake. GBV correlated with body mass index ( p < .05). Among various age groups, no significant differences were noted, across the measured parameters, for both preprandial and postprandial states ( p > .05). Conclusion: In this cohort of participants, navel oranges served as an alternative to fasting for gallbladder sonographic preparation and did not affect image quality.
- 28 February 2025
- Published by SAGE Publications in Journal of Diagnostic Medical Sonography
- Vol. 41 (6) , 575-582
Effects of Low-Fat Food on Gallbladder Contraction and Sonographic Image Quality
Objective: The aim of this study was to examine the impact of consuming a navel orange, a low-fat food item, on gallbladder contraction and sonographic image quality. Materials and Methods: Sixty-six healthy Chinese participants underwent sonographic evaluation of their gallbladder volume (GBV) and anterior wall thickness (AWT) after fasting for at least 6 hours. This protocol was repeated 120 minutes after consuming a navel orange. An experienced sonographer rated the quality of the gallbladder images on a five-point Likert scale. Results: There was no significant change in GBV (14.15 cm³ preprandial vs 14.00 cm³ postprandial, p =.073), AWT (0.154 cm vs 0.157 cm, p =.101), or image quality (both rated 5, p =1.000) after orange intake. GBV correlated with body mass index ( p < .05). Among various age groups, no significant differences were noted, across the measured parameters, for both preprandial and postprandial states ( p > .05). Conclusion: In this cohort of participants, navel oranges served as an alternative to fasting for gallbladder sonographic preparation and did not affect image quality.
- Open Access
- 1 January 2025
- Published by SAGE Publications in Journal of Alzheimer's Disease Reports
- Vol. 9
Comparative analysis of PET and multiparametric MRI biomarkers in Alzheimer's disease continuum cohort
Background: Non-invasive biomarkers are key to early Alzheimer's disease (AD) detection. Multiparametric MRI and advanced imaging offer promising, accessible tools for identifying AD-related changes, supporting timely diagnosis and intervention. Objective: To assess how accurately multiparametric MRI biomarkers identify AD using Aβ-PET imaging as the reference, and to evaluate whether MRI metrics in AD-related brain regions can distinguish between Aβ-positive and Aβ-negative subjects across the AD continuum. Methods: In this exploratory retrospective study, 44 subjects aged 50–80 years were classified based on their PET and MRI biomarkers following the NIA-AA 2024 framework. MRI metrics included selected regional brain volumes (T1-weighted), mean diffusivity and fractional anisotropy (DTI-MD, DTI-FA), quantitative susceptibility mapping (QSM), and T1rho imaging. These were compared with amyloid load, and diagnostic performance was assessed using area-under-the-curve (AUC) analysis. Results: 25 subjects were Aβ+ (AD continuum), while 19 were Aβ- (controls). Volumes of the hippocampus, thalamus, amygdala, cingulate, putamen, and corpus callosum and DTI-MD in the hippocampus, corpus callosum, cuneus, and cingulate showed optimal diagnostic performance (AUC ≥ 0.80), with hippocampal volume and hippocampal DTI-MD showing AUCs > 0.90, (both p < 0.05). Combining hippocampal volumetry and hippocampal DTI-MD (AUC = 0.95, p < 0.001) improved diagnostic accuracy by 2.1% compared to using either biomarker alone. LASSO logistic regression analysis showed that amyloid positivity was significantly associated with hippocampal volume (p < 0.001). Conclusions: Hippocampal volumetry and hippocampal DTI-MD may be superior and more sensitive imaging biomarkers for AD. Their combined use could improve diagnostic accuracy and enhance early AD detection.
- 1 January 2025
- Published by SAGE Publications in Journal of Alzheimer's Disease Reports
- Vol. 9
Open AccessComparative analysis of PET and multiparametric MRI biomarkers in Alzheimer's disease continuum cohort
Background: Non-invasive biomarkers are key to early Alzheimer's disease (AD) detection. Multiparametric MRI and advanced imaging offer promising, accessible tools for identifying AD-related changes, supporting timely diagnosis and intervention. Objective: To assess how accurately multiparametric MRI biomarkers identify AD using Aβ-PET imaging as the reference, and to evaluate whether MRI metrics in AD-related brain regions can distinguish between Aβ-positive and Aβ-negative subjects across the AD continuum. Methods: In this exploratory retrospective study, 44 subjects aged 50–80 years were classified based on their PET and MRI biomarkers following the NIA-AA 2024 framework. MRI metrics included selected regional brain volumes (T1-weighted), mean diffusivity and fractional anisotropy (DTI-MD, DTI-FA), quantitative susceptibility mapping (QSM), and T1rho imaging. These were compared with amyloid load, and diagnostic performance was assessed using area-under-the-curve (AUC) analysis. Results: 25 subjects were Aβ+ (AD continuum), while 19 were Aβ- (controls). Volumes of the hippocampus, thalamus, amygdala, cingulate, putamen, and corpus callosum and DTI-MD in the hippocampus, corpus callosum, cuneus, and cingulate showed optimal diagnostic performance (AUC ≥ 0.80), with hippocampal volume and hippocampal DTI-MD showing AUCs > 0.90, (both p < 0.05). Combining hippocampal volumetry and hippocampal DTI-MD (AUC = 0.95, p < 0.001) improved diagnostic accuracy by 2.1% compared to using either biomarker alone. LASSO logistic regression analysis showed that amyloid positivity was significantly associated with hippocampal volume (p < 0.001). Conclusions: Hippocampal volumetry and hippocampal DTI-MD may be superior and more sensitive imaging biomarkers for AD. Their combined use could improve diagnostic accuracy and enhance early AD detection.
- Open Access
- 22 October 2024
- Published by Wiley in Clinical Obesity
- Vol. 15 (1) , e12712
Gamma‐glutamyl transferase: A potential biomarker for pancreas steatosis in patients with concurrent obesity, insulin resistance and metabolic dysfunction‐associated steatotic liver disease
Summary: To evaluate the relationship between serum gamma‐glutamyl transferase (GGT) levels and fatty pancreas in subjects with concurrent obesity, insulin resistance and metabolic dysfunction‐associated steatotic liver disease (MASLD) without a history of pancreatitis. From March 2019 to September 2021, 31 adult subjects with concurrent obesity and MASLD were recruited as part of the study investigating the biological impact of bariatric surgery and lifestyle modification on obesity. Chemical shift encoded MRI of the abdomen, LiverMultiScan, anthropometric, clinical and blood biochemistry analyses were performed prior to any intervention at baseline. GGT (p <.001) was significantly different between those ‘with fatty pancreas’ and ‘without fatty pancreas’ groups. GGT (p <.001) was significantly different between those ‘with both metabolic syndrome and fatty pancreas’ and those ‘with metabolic syndrome but without fatty pancreas.’ GGT (p <.001) was also significantly different between those ‘with both diabetes and fatty pancreas’ and those ‘with diabetes but without fatty pancreas’. Logistic regression analysis showed that abnormal GGT levels (p = .010) and Hypertension (p = .045) were significant independent predictors of fatty pancreas. GGT was associated with fatty pancreas by an odds ratio 7.333 (95% [CI]: 1.467–36.664), while the AUROC of GGT in determining fatty pancreas was 0.849. Elevation in serum GGT might be a potential marker to identify fatty pancreas.
- 22 October 2024
- Published by Wiley in Clinical Obesity
- Vol. 15 (1) , e12712
Open AccessGamma‐glutamyl transferase: A potential biomarker for pancreas steatosis in patients with concurrent obesity, insulin resistance and metabolic dysfunction‐associated steatotic liver disease
Summary: To evaluate the relationship between serum gamma‐glutamyl transferase (GGT) levels and fatty pancreas in subjects with concurrent obesity, insulin resistance and metabolic dysfunction‐associated steatotic liver disease (MASLD) without a history of pancreatitis. From March 2019 to September 2021, 31 adult subjects with concurrent obesity and MASLD were recruited as part of the study investigating the biological impact of bariatric surgery and lifestyle modification on obesity. Chemical shift encoded MRI of the abdomen, LiverMultiScan, anthropometric, clinical and blood biochemistry analyses were performed prior to any intervention at baseline. GGT (p <.001) was significantly different between those ‘with fatty pancreas’ and ‘without fatty pancreas’ groups. GGT (p <.001) was significantly different between those ‘with both metabolic syndrome and fatty pancreas’ and those ‘with metabolic syndrome but without fatty pancreas.’ GGT (p <.001) was also significantly different between those ‘with both diabetes and fatty pancreas’ and those ‘with diabetes but without fatty pancreas’. Logistic regression analysis showed that abnormal GGT levels (p = .010) and Hypertension (p = .045) were significant independent predictors of fatty pancreas. GGT was associated with fatty pancreas by an odds ratio 7.333 (95% [CI]: 1.467–36.664), while the AUROC of GGT in determining fatty pancreas was 0.849. Elevation in serum GGT might be a potential marker to identify fatty pancreas.
- Open Access
- 1 July 2024
- Published by AME Publishing Company in Quantitative Imaging in Medicine and Surgery
- Vol. 14 (7) , 4659-4674
The effectiveness of magnetic resonance imaging (MRI) iron corrected T1 in monitoring metabolic dysfunction-associated steatohepatitis in obesity following bariatric surgery and lifestyle modification: a prospective cohort study
Background: Bariatric surgery and lifestyle modification are important treatments for obesity, a risk factor for metabolic dysfunction-associated steatohepatitis (MASH). Studies have related weight reduction with changes in MASH, however, few have used imaging to investigate effects on liver health. We evaluated differences in liver response to obesity treatment using disease activity iron corrected T1 (cT1) and proton density fat fraction (PDFF) in patients with both obesity and metabolic dysfunction-associated steatotic liver disease (MASLD). Methods: Thirty-four patients with obesity and MASLD were recruited between March 2019 to February 2022 from a tertiary hospital in this longitudinal study; 13 underwent laparoscopic sleeve gastrectomy (LSG) alongside intraoperative liver biopsy, and 21 underwent a 4-month lifestyle modification program (LMP). All patients had multi-parametric magnetic resonance imaging (MRI) at baseline and 4-months. Diagnostic accuracy to identify MASH was assessed using the area under receiver operating characteristic (AUROC) curve. Results: Four (31%) of patients in the LSG group had MASH [non-alcoholic steatohepatitis (NAS) activity score ≥4] on liver biopsy. PDFF and cT1 correlated with the NAS activity score [r=0.81, 95% confidence interval (CI): 0.453 to 0.943, Pvs. −1.3% (P=0.262) resulted in cT1 reduction of −8.04% (864 ms, P=0.025) vs. −3.87% (907 ms, P=0.083) in the LSG vs. LMP group, respectively. Significant differences between interventions were observed for percentage PDFF decrease (−64.52% vs. −29.16%, P=0.001). Both biomarkers were significantly reduced in the LSG group (cT1 by −8.04%, P=0.025, PDFF by −64.52%, P=0.012), while only PDFF (−29.16%, P=0.012) was significantly reduced in the LMP group. Conclusions: MRI biomarkers may have some utility to monitor MASH following intervention in patients with obesity allowing objective comparison between intervention strategies. Compared to LMP, LSG was more effective in improving liver health.
- 1 July 2024
- Published by AME Publishing Company in Quantitative Imaging in Medicine and Surgery
- Vol. 14 (7) , 4659-4674
Open AccessThe effectiveness of magnetic resonance imaging (MRI) iron corrected T1 in monitoring metabolic dysfunction-associated steatohepatitis in obesity following bariatric surgery and lifestyle modification: a prospective cohort study
Background: Bariatric surgery and lifestyle modification are important treatments for obesity, a risk factor for metabolic dysfunction-associated steatohepatitis (MASH). Studies have related weight reduction with changes in MASH, however, few have used imaging to investigate effects on liver health. We evaluated differences in liver response to obesity treatment using disease activity iron corrected T1 (cT1) and proton density fat fraction (PDFF) in patients with both obesity and metabolic dysfunction-associated steatotic liver disease (MASLD). Methods: Thirty-four patients with obesity and MASLD were recruited between March 2019 to February 2022 from a tertiary hospital in this longitudinal study; 13 underwent laparoscopic sleeve gastrectomy (LSG) alongside intraoperative liver biopsy, and 21 underwent a 4-month lifestyle modification program (LMP). All patients had multi-parametric magnetic resonance imaging (MRI) at baseline and 4-months. Diagnostic accuracy to identify MASH was assessed using the area under receiver operating characteristic (AUROC) curve. Results: Four (31%) of patients in the LSG group had MASH [non-alcoholic steatohepatitis (NAS) activity score ≥4] on liver biopsy. PDFF and cT1 correlated with the NAS activity score [r=0.81, 95% confidence interval (CI): 0.453 to 0.943, Pvs. −1.3% (P=0.262) resulted in cT1 reduction of −8.04% (864 ms, P=0.025) vs. −3.87% (907 ms, P=0.083) in the LSG vs. LMP group, respectively. Significant differences between interventions were observed for percentage PDFF decrease (−64.52% vs. −29.16%, P=0.001). Both biomarkers were significantly reduced in the LSG group (cT1 by −8.04%, P=0.025, PDFF by −64.52%, P=0.012), while only PDFF (−29.16%, P=0.012) was significantly reduced in the LMP group. Conclusions: MRI biomarkers may have some utility to monitor MASH following intervention in patients with obesity allowing objective comparison between intervention strategies. Compared to LMP, LSG was more effective in improving liver health.
- Open Access
- 29 April 2020
- Published by Wiley in Pediatric Obesity
- Vol. 15 (9) , e12653
The relationship between pancreas steatosis and the risk of metabolic syndrome and insulin resistance in Chinese adolescents with concurrent obesity and non‐alcoholic fatty liver disease
Summary: Background: The incidence of childhood obesity and associated comorbidities are on an increasing trend worldwide. More than 340 million children and adolescents aged between 5 and 19 years old were overweight or had obesity in 2016, from which over 124 million children and adolescents (6% of girls and 8% of boys) had obesity.Objective: To describe the relationship between pancreas steatosis, body fat and the risk of metabolic syndrome, insulin resistance in Hong Kong Chinese adolescents with both obesity and non‐alcoholic fatty liver disease (NAFLD).Methods: Fifty two adolescents with obesity and NAFLD were analysed (14‐18 years), stratified into fatty and non‐fatty pancreas groups using chemical shift encoded MRI‐pancreas proton density fat fraction ≥5%. Pancreatic, abdominal subcutaneous adipose tissue (SAT)/visceral adipose tissue (VAT) volumes, biochemical and anthropometric parameters were measured. Mann‐Whitney U test, multiple linear/binary logistic regression analyses and odds ratios were used.Results: Fifty percent had fatty pancreas, 38% had metabolic syndrome and 81% had insulin resistance. Liver proton density fat fraction (PDFF) and VAT were independent predictors of insulin resistance (P = .006, .016). Pancreas and liver PDFF were both independent predictors of beta cells dysfunction (P = .015, .050) and metabolic syndrome (P = .021, .041). Presence of fatty pancreas in obesity was associated with insulin resistance (OR = 1.58, 95% CI = 0.39‐6.4) and metabolic syndrome (OR = 1.70, 95% CI = 0.53‐5.5).Conclusion: A significant causal relationship exists between fatty pancreas, fatty liver, body fat and the risk of developing metabolic syndrome and insulin resistance.Key Points: Fatty pancreas is a common finding in adolescents with obesity, with a prevalence rate of 50% in this study cohort. Liver PDFF and VAT are independent predictors of insulin resistance while pancreas PDFF and liver PDFF are independent predictors of both beta cells dysfunction and metabolic syndrome. Presence of fatty pancreas at imaging should not be considered as a benign finding but rather as an imaging biomarker of emerging pancreatic metabolic and endocrine dysfunction.
- 29 April 2020
- Published by Wiley in Pediatric Obesity
- Vol. 15 (9) , e12653
Open AccessThe relationship between pancreas steatosis and the risk of metabolic syndrome and insulin resistance in Chinese adolescents with concurrent obesity and non‐alcoholic fatty liver disease
Summary: Background: The incidence of childhood obesity and associated comorbidities are on an increasing trend worldwide. More than 340 million children and adolescents aged between 5 and 19 years old were overweight or had obesity in 2016, from which over 124 million children and adolescents (6% of girls and 8% of boys) had obesity.Objective: To describe the relationship between pancreas steatosis, body fat and the risk of metabolic syndrome, insulin resistance in Hong Kong Chinese adolescents with both obesity and non‐alcoholic fatty liver disease (NAFLD).Methods: Fifty two adolescents with obesity and NAFLD were analysed (14‐18 years), stratified into fatty and non‐fatty pancreas groups using chemical shift encoded MRI‐pancreas proton density fat fraction ≥5%. Pancreatic, abdominal subcutaneous adipose tissue (SAT)/visceral adipose tissue (VAT) volumes, biochemical and anthropometric parameters were measured. Mann‐Whitney U test, multiple linear/binary logistic regression analyses and odds ratios were used.Results: Fifty percent had fatty pancreas, 38% had metabolic syndrome and 81% had insulin resistance. Liver proton density fat fraction (PDFF) and VAT were independent predictors of insulin resistance (P = .006, .016). Pancreas and liver PDFF were both independent predictors of beta cells dysfunction (P = .015, .050) and metabolic syndrome (P = .021, .041). Presence of fatty pancreas in obesity was associated with insulin resistance (OR = 1.58, 95% CI = 0.39‐6.4) and metabolic syndrome (OR = 1.70, 95% CI = 0.53‐5.5).Conclusion: A significant causal relationship exists between fatty pancreas, fatty liver, body fat and the risk of developing metabolic syndrome and insulin resistance.Key Points: Fatty pancreas is a common finding in adolescents with obesity, with a prevalence rate of 50% in this study cohort. Liver PDFF and VAT are independent predictors of insulin resistance while pancreas PDFF and liver PDFF are independent predictors of both beta cells dysfunction and metabolic syndrome. Presence of fatty pancreas at imaging should not be considered as a benign finding but rather as an imaging biomarker of emerging pancreatic metabolic and endocrine dysfunction.